 Katja Gist
Concepts (304)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acute Kidney Injury | 91 | 2025 | 811 | 20.780 |
Why?
| | Cardiac Surgical Procedures | 26 | 2025 | 531 | 8.020 |
Why?
| | Water-Electrolyte Imbalance | 14 | 2024 | 44 | 4.620 |
Why?
| | Creatinine | 18 | 2024 | 501 | 3.670 |
Why?
| | Postoperative Complications | 22 | 2024 | 2641 | 3.420 |
Why?
| | Critical Illness | 24 | 2025 | 809 | 3.360 |
Why?
| | Lipocalin-2 | 6 | 2025 | 79 | 2.990 |
Why?
| | Heart Defects, Congenital | 10 | 2025 | 832 | 2.500 |
Why?
| | Milrinone | 5 | 2021 | 29 | 2.390 |
Why?
| | Renal Replacement Therapy | 15 | 2025 | 92 | 2.390 |
Why?
| | Extracorporeal Membrane Oxygenation | 7 | 2024 | 292 | 2.360 |
Why?
| | Biomarkers | 20 | 2025 | 4172 | 2.080 |
Why?
| | Cardiopulmonary Bypass | 7 | 2024 | 209 | 2.010 |
Why?
| | Infant, Newborn | 52 | 2025 | 6059 | 2.010 |
Why?
| | Norwood Procedures | 4 | 2024 | 29 | 1.910 |
Why?
| | Child | 71 | 2025 | 22037 | 1.810 |
Why?
| | Peritoneal Dialysis | 3 | 2020 | 97 | 1.760 |
Why?
| | Chlorides | 3 | 2020 | 140 | 1.720 |
Why?
| | Retrospective Studies | 63 | 2025 | 15628 | 1.590 |
Why?
| | Infant | 40 | 2025 | 9467 | 1.420 |
Why?
| | Kidney | 15 | 2024 | 1472 | 1.400 |
Why?
| | Arterial Switch Operation | 2 | 2020 | 9 | 1.380 |
Why?
| | Risk Factors | 36 | 2025 | 10356 | 1.360 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2018 | 121 | 1.320 |
Why?
| | Furosemide | 3 | 2024 | 37 | 1.270 |
Why?
| | Humans | 125 | 2025 | 137514 | 1.270 |
Why?
| | Prospective Studies | 22 | 2025 | 7598 | 1.240 |
Why?
| | Child, Preschool | 35 | 2025 | 11097 | 1.220 |
Why?
| | Intensive Care Units, Pediatric | 11 | 2025 | 233 | 1.120 |
Why?
| | Heart Diseases | 3 | 2025 | 359 | 1.120 |
Why?
| | Male | 71 | 2025 | 67718 | 1.100 |
Why?
| | Water-Electrolyte Balance | 7 | 2025 | 34 | 1.100 |
Why?
| | Hospital Mortality | 13 | 2024 | 902 | 1.100 |
Why?
| | Hypoxia-Ischemia, Brain | 2 | 2024 | 37 | 1.020 |
Why?
| | Female | 68 | 2025 | 73162 | 1.000 |
Why?
| | Sepsis | 3 | 2024 | 611 | 0.940 |
Why?
| | Heart Failure | 5 | 2023 | 2222 | 0.920 |
Why?
| | Chemokines, CC | 1 | 2024 | 33 | 0.920 |
Why?
| | Sodium Potassium Chloride Symporter Inhibitors | 1 | 2024 | 16 | 0.900 |
Why?
| | Length of Stay | 13 | 2025 | 1210 | 0.900 |
Why?
| | Shock, Cardiogenic | 1 | 2024 | 63 | 0.880 |
Why?
| | Infant, Premature, Diseases | 1 | 2025 | 101 | 0.880 |
Why?
| | Hypertension | 2 | 2023 | 1293 | 0.840 |
Why?
| | Reperfusion Injury | 2 | 2022 | 279 | 0.810 |
Why?
| | Respiration, Artificial | 11 | 2025 | 643 | 0.800 |
Why?
| | Critical Care | 6 | 2024 | 584 | 0.790 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2022 | 250 | 0.770 |
Why?
| | Tissue Inhibitor of Metalloproteinase-2 | 3 | 2021 | 15 | 0.740 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 3 | 2021 | 26 | 0.730 |
Why?
| | Cardio-Renal Syndrome | 2 | 2019 | 12 | 0.720 |
Why?
| | Adolescent | 30 | 2025 | 21555 | 0.700 |
Why?
| | Phenotype | 3 | 2024 | 3205 | 0.700 |
Why?
| | Cystatin C | 2 | 2021 | 65 | 0.660 |
Why?
| | Glomerular Filtration Rate | 3 | 2022 | 746 | 0.640 |
Why?
| | Fontan Procedure | 2 | 2019 | 179 | 0.620 |
Why?
| | Aorta, Thoracic | 1 | 2021 | 267 | 0.610 |
Why?
| | Registries | 9 | 2025 | 2021 | 0.610 |
Why?
| | Erythropoietin | 3 | 2025 | 95 | 0.600 |
Why?
| | Fluid Therapy | 1 | 2020 | 147 | 0.600 |
Why?
| | Esthetics | 1 | 2018 | 52 | 0.590 |
Why?
| | Intensive Care Units | 9 | 2024 | 803 | 0.580 |
Why?
| | Cicatrix | 1 | 2018 | 64 | 0.580 |
Why?
| | Publications | 1 | 2018 | 45 | 0.570 |
Why?
| | Pacemaker, Artificial | 1 | 2018 | 119 | 0.550 |
Why?
| | Renal Insufficiency | 1 | 2019 | 157 | 0.530 |
Why?
| | Vasodilator Agents | 2 | 2016 | 333 | 0.530 |
Why?
| | Postoperative Care | 1 | 2018 | 258 | 0.530 |
Why?
| | Jugular Veins | 2 | 2019 | 42 | 0.530 |
Why?
| | Reoperation | 1 | 2019 | 569 | 0.520 |
Why?
| | Treatment Outcome | 17 | 2025 | 10821 | 0.500 |
Why?
| | Consensus | 6 | 2025 | 685 | 0.500 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2016 | 56 | 0.490 |
Why?
| | Defibrillators, Implantable | 1 | 2018 | 316 | 0.470 |
Why?
| | Brain | 3 | 2024 | 2831 | 0.440 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 2014 | 34 | 0.440 |
Why?
| | Young Adult | 20 | 2025 | 13243 | 0.440 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 1002 | 0.440 |
Why?
| | Diuretics | 3 | 2024 | 74 | 0.410 |
Why?
| | Hepatitis A Virus Cellular Receptor 1 | 3 | 2024 | 42 | 0.410 |
Why?
| | Pulmonary Valve Stenosis | 1 | 2013 | 18 | 0.400 |
Why?
| | Heparin | 1 | 2014 | 259 | 0.390 |
Why?
| | Renal Dialysis | 4 | 2024 | 434 | 0.390 |
Why?
| | Lipocalins | 2 | 2024 | 37 | 0.390 |
Why?
| | Venous Thrombosis | 1 | 2014 | 187 | 0.380 |
Why?
| | Hypothermia, Induced | 2 | 2024 | 79 | 0.370 |
Why?
| | Anticoagulants | 3 | 2023 | 665 | 0.360 |
Why?
| | Magnetic Resonance Imaging | 1 | 2024 | 3722 | 0.360 |
Why?
| | Pulmonary Valve Insufficiency | 1 | 2012 | 43 | 0.360 |
Why?
| | Systemic Inflammatory Response Syndrome | 5 | 2022 | 95 | 0.350 |
Why?
| | Body Surface Potential Mapping | 1 | 2010 | 8 | 0.350 |
Why?
| | Quality of Life | 2 | 2023 | 2870 | 0.350 |
Why?
| | Risk Assessment | 7 | 2025 | 3439 | 0.350 |
Why?
| | Aspirin | 1 | 2014 | 385 | 0.350 |
Why?
| | Cohort Studies | 9 | 2024 | 5730 | 0.350 |
Why?
| | Tachycardia, Atrioventricular Nodal Reentry | 1 | 2010 | 30 | 0.340 |
Why?
| | Thrombocytopenia | 2 | 2025 | 199 | 0.340 |
Why?
| | Predictive Value of Tests | 3 | 2025 | 2039 | 0.340 |
Why?
| | Incidence | 4 | 2022 | 2792 | 0.330 |
Why?
| | Intensive Care Units, Neonatal | 5 | 2024 | 252 | 0.320 |
Why?
| | Gestational Age | 6 | 2025 | 903 | 0.320 |
Why?
| | Renal Insufficiency, Chronic | 3 | 2025 | 616 | 0.320 |
Why?
| | Tachycardia, Supraventricular | 1 | 2009 | 45 | 0.320 |
Why?
| | Severity of Illness Index | 6 | 2024 | 2838 | 0.310 |
Why?
| | Models, Biological | 2 | 2019 | 1775 | 0.310 |
Why?
| | Heart Conduction System | 1 | 2009 | 100 | 0.310 |
Why?
| | Cryosurgery | 1 | 2009 | 59 | 0.310 |
Why?
| | Prognosis | 6 | 2025 | 4031 | 0.310 |
Why?
| | Cardiotonic Agents | 2 | 2021 | 126 | 0.300 |
Why?
| | Heart | 3 | 2022 | 660 | 0.290 |
Why?
| | Delphi Technique | 3 | 2024 | 273 | 0.290 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2023 | 382 | 0.280 |
Why?
| | Ischemia | 2 | 2022 | 408 | 0.280 |
Why?
| | Time Factors | 8 | 2022 | 6817 | 0.280 |
Why?
| | Child, Hospitalized | 3 | 2022 | 53 | 0.270 |
Why?
| | Catheter Ablation | 1 | 2010 | 349 | 0.270 |
Why?
| | Pulmonary Artery | 1 | 2013 | 1083 | 0.260 |
Why?
| | Survival Rate | 4 | 2024 | 1980 | 0.260 |
Why?
| | Vasoconstrictor Agents | 2 | 2024 | 138 | 0.260 |
Why?
| | Age Factors | 6 | 2022 | 3301 | 0.260 |
Why?
| | Heart Transplantation | 2 | 2022 | 749 | 0.250 |
Why?
| | Logistic Models | 5 | 2024 | 2064 | 0.250 |
Why?
| | Quality Improvement | 3 | 2024 | 1161 | 0.240 |
Why?
| | Interleukin-18 | 2 | 2024 | 237 | 0.240 |
Why?
| | Postoperative Period | 3 | 2024 | 344 | 0.240 |
Why?
| | Nomograms | 1 | 2025 | 54 | 0.230 |
Why?
| | Infant, Extremely Premature | 1 | 2025 | 66 | 0.230 |
Why?
| | Bumetanide | 1 | 2024 | 5 | 0.230 |
Why?
| | Renin | 1 | 2024 | 34 | 0.230 |
Why?
| | Comorbidity | 5 | 2022 | 1618 | 0.220 |
Why?
| | Addison Disease | 1 | 2024 | 43 | 0.220 |
Why?
| | Adrenal Insufficiency | 1 | 2024 | 32 | 0.220 |
Why?
| | Acute Disease | 5 | 2023 | 1008 | 0.220 |
Why?
| | Vasopressins | 1 | 2024 | 64 | 0.220 |
Why?
| | Consent Forms | 1 | 2023 | 11 | 0.220 |
Why?
| | Infant, Premature | 4 | 2024 | 568 | 0.210 |
Why?
| | Cardiac Output, Low | 2 | 2021 | 66 | 0.210 |
Why?
| | Global Health | 2 | 2024 | 386 | 0.210 |
Why?
| | Multiple Organ Failure | 1 | 2024 | 127 | 0.210 |
Why?
| | Health Information Systems | 1 | 2022 | 18 | 0.200 |
Why?
| | Odds Ratio | 3 | 2022 | 1063 | 0.200 |
Why?
| | Informed Consent | 1 | 2023 | 170 | 0.200 |
Why?
| | Hydrocortisone | 1 | 2024 | 318 | 0.190 |
Why?
| | Forecasting | 1 | 2024 | 386 | 0.190 |
Why?
| | Proportional Hazards Models | 1 | 2025 | 1263 | 0.190 |
Why?
| | Hypernatremia | 1 | 2021 | 8 | 0.190 |
Why?
| | Infant, Newborn, Diseases | 1 | 2023 | 113 | 0.190 |
Why?
| | Nephrology | 1 | 2022 | 61 | 0.190 |
Why?
| | Sodium | 1 | 2022 | 218 | 0.180 |
Why?
| | Hyponatremia | 1 | 2021 | 42 | 0.180 |
Why?
| | Hyperglycemia | 1 | 2025 | 346 | 0.180 |
Why?
| | Surveys and Questionnaires | 5 | 2024 | 5772 | 0.180 |
Why?
| | Benzodiazepines | 1 | 2022 | 153 | 0.180 |
Why?
| | Mice, Inbred C57BL | 2 | 2022 | 5792 | 0.180 |
Why?
| | Coinfection | 1 | 2022 | 137 | 0.180 |
Why?
| | Survival Analysis | 3 | 2020 | 1320 | 0.180 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2022 | 211 | 0.170 |
Why?
| | Adult | 13 | 2025 | 37821 | 0.170 |
Why?
| | Adenosine Monophosphate | 1 | 2021 | 66 | 0.170 |
Why?
| | Catheters, Indwelling | 1 | 2020 | 83 | 0.170 |
Why?
| | Perfusion | 1 | 2021 | 212 | 0.170 |
Why?
| | Child Development | 1 | 2025 | 474 | 0.170 |
Why?
| | Multivariate Analysis | 1 | 2024 | 1524 | 0.170 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2022 | 252 | 0.160 |
Why?
| | Bicarbonates | 1 | 2020 | 46 | 0.160 |
Why?
| | Metabolic Clearance Rate | 2 | 2019 | 117 | 0.160 |
Why?
| | Machine Learning | 1 | 2024 | 496 | 0.160 |
Why?
| | Phosphodiesterase 3 Inhibitors | 1 | 2019 | 14 | 0.160 |
Why?
| | Bioprosthesis | 1 | 2019 | 41 | 0.150 |
Why?
| | Heart Failure, Diastolic | 1 | 2019 | 21 | 0.150 |
Why?
| | Guideline Adherence | 1 | 2023 | 549 | 0.150 |
Why?
| | Asphyxia Neonatorum | 1 | 2018 | 18 | 0.150 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2021 | 201 | 0.150 |
Why?
| | Kinetics | 2 | 2024 | 1679 | 0.150 |
Why?
| | Kidney Function Tests | 1 | 2019 | 158 | 0.150 |
Why?
| | Recurrence | 2 | 2019 | 1060 | 0.140 |
Why?
| | Echocardiography | 3 | 2019 | 659 | 0.140 |
Why?
| | Propensity Score | 1 | 2019 | 288 | 0.140 |
Why?
| | Neonatologists | 1 | 2017 | 7 | 0.140 |
Why?
| | Heart Valve Prosthesis | 1 | 2019 | 116 | 0.140 |
Why?
| | Nephrologists | 1 | 2017 | 12 | 0.140 |
Why?
| | Heart Valve Diseases | 1 | 2019 | 152 | 0.140 |
Why?
| | Pulmonary Valve | 1 | 2019 | 98 | 0.140 |
Why?
| | Inpatients | 1 | 2022 | 502 | 0.140 |
Why?
| | Early Medical Intervention | 1 | 2018 | 58 | 0.140 |
Why?
| | Fibroblast Growth Factors | 1 | 2018 | 171 | 0.140 |
Why?
| | Brain Diseases | 1 | 2018 | 141 | 0.140 |
Why?
| | Chi-Square Distribution | 2 | 2021 | 533 | 0.130 |
Why?
| | Follow-Up Studies | 4 | 2025 | 5139 | 0.130 |
Why?
| | ROC Curve | 3 | 2024 | 547 | 0.130 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2019 | 182 | 0.130 |
Why?
| | Cell Cycle Checkpoints | 1 | 2017 | 98 | 0.130 |
Why?
| | Early Diagnosis | 1 | 2018 | 244 | 0.130 |
Why?
| | Pilot Projects | 2 | 2021 | 1703 | 0.130 |
Why?
| | Immunocompromised Host | 1 | 2018 | 203 | 0.130 |
Why?
| | Research Design | 1 | 2022 | 1116 | 0.130 |
Why?
| | Thoracic Surgery | 1 | 2018 | 133 | 0.130 |
Why?
| | Pain | 1 | 2022 | 836 | 0.120 |
Why?
| | Hemodynamics | 1 | 2021 | 1114 | 0.120 |
Why?
| | Hospitalization | 3 | 2021 | 2197 | 0.120 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2019 | 2066 | 0.120 |
Why?
| | Algorithms | 1 | 2022 | 1702 | 0.120 |
Why?
| | United States | 6 | 2023 | 14696 | 0.110 |
Why?
| | Cattle | 2 | 2019 | 982 | 0.110 |
Why?
| | Cross-Sectional Studies | 3 | 2022 | 5427 | 0.110 |
Why?
| | Tachycardia | 1 | 2014 | 58 | 0.110 |
Why?
| | Pediatric Obesity | 1 | 2021 | 592 | 0.110 |
Why?
| | Bayes Theorem | 1 | 2015 | 407 | 0.110 |
Why?
| | Blalock-Taussig Procedure | 1 | 2013 | 5 | 0.100 |
Why?
| | Birth Weight | 3 | 2023 | 516 | 0.100 |
Why?
| | Feasibility Studies | 1 | 2017 | 950 | 0.100 |
Why?
| | Aminoglycosides | 2 | 2023 | 24 | 0.100 |
Why?
| | Fetal Growth Retardation | 1 | 2018 | 565 | 0.100 |
Why?
| | Mice | 4 | 2022 | 17843 | 0.100 |
Why?
| | Animals | 6 | 2022 | 37011 | 0.100 |
Why?
| | Oxidative Stress | 1 | 2019 | 1307 | 0.090 |
Why?
| | Catheterization | 1 | 2013 | 179 | 0.090 |
Why?
| | Ventricular Function, Right | 1 | 2014 | 283 | 0.090 |
Why?
| | Organ Size | 1 | 2012 | 479 | 0.090 |
Why?
| | Coronary Angiography | 1 | 2013 | 314 | 0.090 |
Why?
| | Colorado | 2 | 2018 | 4521 | 0.080 |
Why?
| | Pulmonary Embolism | 1 | 2012 | 222 | 0.080 |
Why?
| | Fluoroscopy | 1 | 2010 | 162 | 0.080 |
Why?
| | Age Distribution | 2 | 2022 | 391 | 0.080 |
Why?
| | Professional Competence | 1 | 2010 | 100 | 0.080 |
Why?
| | Acute-Phase Proteins | 2 | 2019 | 67 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2017 | 1332 | 0.070 |
Why?
| | Aging | 1 | 2019 | 1866 | 0.070 |
Why?
| | Practice Patterns, Physicians' | 1 | 2017 | 1312 | 0.070 |
Why?
| | Aged | 3 | 2022 | 23798 | 0.070 |
Why?
| | Body Weight | 2 | 2025 | 973 | 0.070 |
Why?
| | Neoplasms | 1 | 2022 | 2666 | 0.070 |
Why?
| | India | 2 | 2018 | 193 | 0.070 |
Why?
| | Canada | 2 | 2019 | 421 | 0.070 |
Why?
| | Hospitals, Pediatric | 2 | 2020 | 533 | 0.060 |
Why?
| | Platelet Count | 1 | 2025 | 86 | 0.060 |
Why?
| | Databases, Factual | 2 | 2022 | 1351 | 0.060 |
Why?
| | Body Height | 1 | 2025 | 201 | 0.050 |
Why?
| | Organ Dysfunction Scores | 1 | 2024 | 47 | 0.050 |
Why?
| | Neuroprotection | 1 | 2023 | 42 | 0.050 |
Why?
| | Parenteral Nutrition, Total | 1 | 2022 | 26 | 0.050 |
Why?
| | Potassium | 1 | 2022 | 151 | 0.050 |
Why?
| | Vancomycin | 1 | 2022 | 84 | 0.050 |
Why?
| | Michigan | 1 | 2021 | 108 | 0.050 |
Why?
| | Prostaglandins | 1 | 2021 | 97 | 0.050 |
Why?
| | Confidence Intervals | 1 | 2022 | 328 | 0.040 |
Why?
| | Educational Status | 1 | 2023 | 483 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2023 | 254 | 0.040 |
Why?
| | Societies, Medical | 1 | 2024 | 820 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2012 | 2113 | 0.040 |
Why?
| | Fluid Shifts | 1 | 2019 | 2 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2022 | 4295 | 0.040 |
Why?
| | Graft Survival | 1 | 2022 | 540 | 0.040 |
Why?
| | Matched-Pair Analysis | 1 | 2019 | 40 | 0.040 |
Why?
| | Goals | 1 | 2021 | 168 | 0.040 |
Why?
| | Monte Carlo Method | 1 | 2019 | 145 | 0.040 |
Why?
| | Tertiary Care Centers | 1 | 2020 | 160 | 0.040 |
Why?
| | Term Birth | 1 | 2018 | 23 | 0.040 |
Why?
| | Sex Distribution | 1 | 2019 | 378 | 0.040 |
Why?
| | Hepatocytes | 1 | 2019 | 220 | 0.040 |
Why?
| | Urodynamics | 1 | 2019 | 44 | 0.040 |
Why?
| | Substance Abuse, Intravenous | 1 | 2019 | 114 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2018 | 120 | 0.040 |
Why?
| | Homeostasis | 1 | 2022 | 622 | 0.040 |
Why?
| | Dialysis | 1 | 2017 | 20 | 0.030 |
Why?
| | North America | 1 | 2018 | 313 | 0.030 |
Why?
| | History, 20th Century | 1 | 2019 | 324 | 0.030 |
Why?
| | RNA, Viral | 1 | 2021 | 653 | 0.030 |
Why?
| | New Zealand | 1 | 2017 | 55 | 0.030 |
Why?
| | Prosthesis Design | 1 | 2019 | 309 | 0.030 |
Why?
| | Pregnancy | 2 | 2021 | 6745 | 0.030 |
Why?
| | Australia | 1 | 2017 | 314 | 0.030 |
Why?
| | Sex Factors | 1 | 2022 | 2074 | 0.030 |
Why?
| | Metabolome | 1 | 2019 | 350 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2019 | 778 | 0.030 |
Why?
| | Blood Glucose | 1 | 2025 | 2183 | 0.030 |
Why?
| | Weight Gain | 1 | 2018 | 518 | 0.030 |
Why?
| | Premature Birth | 1 | 2018 | 331 | 0.030 |
Why?
| | Blood Pressure | 1 | 2022 | 1776 | 0.030 |
Why?
| | Middle Aged | 3 | 2022 | 33355 | 0.030 |
Why?
| | Myocardium | 1 | 2019 | 1004 | 0.030 |
Why?
| | Metabolomics | 1 | 2019 | 679 | 0.030 |
Why?
| | Patient Discharge | 1 | 2020 | 895 | 0.030 |
Why?
| | Body Mass Index | 1 | 2022 | 2369 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2019 | 895 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2023 | 1800 | 0.020 |
Why?
| | Pulmonary Surfactants | 1 | 1993 | 106 | 0.020 |
Why?
| | Infant, Low Birth Weight | 1 | 1993 | 141 | 0.020 |
Why?
| | Smoking | 1 | 2019 | 1639 | 0.020 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 1993 | 106 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3546 | 0.020 |
Why?
| | Diabetes Mellitus | 1 | 2019 | 1035 | 0.020 |
Why?
| | Stroke | 1 | 2019 | 1129 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2022 | 7593 | 0.020 |
Why?
| | Diagnostic Imaging | 1 | 2012 | 339 | 0.020 |
Why?
| | Electrocardiography | 1 | 2012 | 632 | 0.020 |
Why?
| | Lung | 1 | 1993 | 4066 | 0.010 |
Why?
| | Fetal Organ Maturity | 1 | 1993 | 27 | 0.010 |
Why?
| | Placebos | 1 | 1993 | 207 | 0.010 |
Why?
| | Cerebral Hemorrhage | 1 | 1993 | 112 | 0.010 |
Why?
| | Retinopathy of Prematurity | 1 | 1993 | 141 | 0.010 |
Why?
| | Cerebral Palsy | 1 | 1993 | 112 | 0.010 |
Why?
| | Intubation, Intratracheal | 1 | 1993 | 259 | 0.010 |
Why?
| | Psychomotor Performance | 1 | 1993 | 326 | 0.010 |
Why?
| | Lung Diseases | 1 | 1993 | 768 | 0.000 |
Why?
|
|
Gist's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|